Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study.
Saved in:
| Title: | Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study. |
|---|---|
| Authors: | Corona A; Laboratory of Precision Medicine of Neurological Diseases, Department of Health Science, University of Milan, Milan, Italy; CRC 'Aldo Ravelli' for Experimental Brain Therapeutics, Department of Health Science, University of Milan, Milan, Italy., Clarelli F; Laboratory of Human Genetics of Neurological Disorders, IRCCS San Raffaele Scientific Institute, Milan, Italy., Pääkkönen K; Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Harroud A; The Neuro (Montreal Neurological Institute-Hospital), Montréal, QC, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada; Department of Human Genetics, McGill University, Montréal, QC, Canada., Shchetynsky K; Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden., Zollo A; Laboratory of Precision Medicine of Neurological Diseases, Department of Health Science, University of Milan, Milan, Italy; CRC 'Aldo Ravelli' for Experimental Brain Therapeutics, Department of Health Science, University of Milan, Milan, Italy., Mingione A; Laboratory of Precision Medicine of Neurological Diseases, Department of Health Science, University of Milan, Milan, Italy; CRC 'Aldo Ravelli' for Experimental Brain Therapeutics, Department of Health Science, University of Milan, Milan, Italy., Sorosina M; Laboratory of Human Genetics of Neurological Disorders, IRCCS San Raffaele Scientific Institute, Milan, Italy., Mascia E; Laboratory of Human Genetics of Neurological Disorders, IRCCS San Raffaele Scientific Institute, Milan, Italy., Giordano A; Laboratory of Human Genetics of Neurological Disorders, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy., Rocca MA; Vita-Salute San Raffaele University, Milan, Italy., Piehl F; Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, CMM L8:05, Stockholm, Sweden., Stridh P; Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden., Hemmer B; Department of Neurology, School of Medicine, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany., Goris A; Laboratory for Neuroimmunology, Department of Neurosciences, KU Leuven Brain Institute, Leuven, Belgium., Dubois B; Laboratory for Neuroimmunology, Department of Neurosciences, KU Leuven Brain Institute, Leuven, Belgium; Department of Neurology, University Hospitals, Leuven, Belgium., Søndergaard HB; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital-Rigshospitalet, Glostrup, Denmark., Sellebjerg F; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital-Rigshospitalet, Glostrup, Denmark., D'alfonso S; Department of Health Sciences, University of Eastern Piedmont, Novara, Italy., Harbo HF; Institute of Clinical Medicine, Medical Faculty, University of Oslo, Oslo, Norway; Department of Neurology, Oslo University Hospital, Oslo, Norway., Olsson T; Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden., Saarela J; Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland., Priori A; CRC 'Aldo Ravelli' for Experimental Brain Therapeutics, Department of Health Science, University of Milan, Milan, Italy; Clinical Neurology Unit, Department of Health Sciences, Azienda Socio-Sanitaria Territoriale Santi Paolo e Carlo, University of Milan, Milan, Italy., Filippi M; Vita-Salute San Raffaele University, Milan, Italy; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy., Kockum I; Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Esposito F; Laboratory of Human Genetics of Neurological Disorders, IRCCS San Raffaele Scientific Institute, Milan, Italy; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Martinelli Boneschi F; Laboratory of Precision Medicine of Neurological Diseases, Department of Health Science, University of Milan, Milan, Italy; CRC 'Aldo Ravelli' for Experimental Brain Therapeutics, Department of Health Science, University of Milan, Milan, Italy; Clinical Neurology Unit, Department of Health Sciences, Azienda Socio-Sanitaria Territoriale Santi Paolo e Carlo, University of Milan, Milan, Italy. |
| Source: | Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2026 Jun; Vol. 32 (7), pp. 747-758. Date of Electronic Publication: 2026 Mar 03. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-0970 |
|---|---|
| DOI: | 10.1177/13524585261417130 |
